Literature DB >> 29455178

Disabling pansclerotic morphoea of childhood.

Indirakshi Jamalpur1, Harikrishna Reddy Mogili2, Abhilash Koratala3.   

Abstract

Disabling pansclerotic morphoea (DPM) of childhood is a severe and often fatal variant of deep morphoea. It usually starts in childhood and rarely seen in adults. The course of the disease is progressive with lifelong morbidity in the form of joint contractures and immobility. The causes of mortality include complications such as sepsis, gangrene and cardiopulmonary involvement. Herein, we discuss the case of a 15-year-old girl with limb deformity and finger contractures, that is, bone involvement. The diagnosis of DPM of childhood was fortuitously made after the correction of limb deformity, when the patient was seen in the dermatology department for evaluation of skin discolouration on the thighs. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  dermatology; neurology; pathology

Mesh:

Year:  2018        PMID: 29455178      PMCID: PMC5836610          DOI: 10.1136/bcr-2017-222132

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Severe ankle deformity secondary to pansclerotic morphea in a 9-year-old girl: correction involving arthrodesis and free flap coverage.

Authors:  Xuan H Nguyen; Ronald Hansen; Francisco Valencia
Journal:  Pediatr Dermatol       Date:  2002 Nov-Dec       Impact factor: 1.588

2.  Morphea in adults and children cohort II: patients with morphea experience delay in diagnosis and large variation in treatment.

Authors:  Weilan Johnson; Heidi Jacobe
Journal:  J Am Acad Dermatol       Date:  2012-02-29       Impact factor: 11.527

3.  Pediatric generalized morphea that developed at a BCG vaccination site.

Authors:  M Matsumoto; T Yamamoto
Journal:  Actas Dermosifiliogr       Date:  2014-09-26

4.  Localized scleroderma in childhood is not just a skin disease.

Authors:  Francesco Zulian; Cristina Vallongo; Patricia Woo; Ricardo Russo; Nicolino Ruperto; John Harper; Graciela Espada; Fabrizia Corona; Masha Mukamel; Richard Vesely; Elzbieta Musiej-Nowakowska; Jeff Chaitow; Joan Ros; Maria T Apaz; Valeria Gerloni; Henryka Mazur-Zielinska; Susan Nielsen; Susanne Ullman; Gerd Horneff; Carine Wouters; Giorgia Martini; Rolando Cimaz; Ronald Laxer; Balu H Athreya
Journal:  Arthritis Rheum       Date:  2005-09

5.  Efficacy of bosentan in treatment of unresponsive cutaneous ulceration in disabling pansclerotic morphea in children.

Authors:  Rosa Roldan; Guadalupe Morote; Maria del Carmen Castro; Maria Dolores Miranda; Jose Carlos Moreno; Eduardo Collantes
Journal:  J Rheumatol       Date:  2006-12       Impact factor: 4.666

Review 6.  Phototherapy: a promising treatment option for skin sclerosis in scleroderma?

Authors:  C Sunderkötter; A Kuhn; N Hunzelmann; S Beissert
Journal:  Rheumatology (Oxford)       Date:  2006-10       Impact factor: 7.580

7.  Disabling pansclerotic morphea: clinical presentation in two adults.

Authors:  Sherry Henderson Maragh; Mark D P Davis; Alison J Bruce; Audrey M Nelson
Journal:  J Am Acad Dermatol       Date:  2005-08       Impact factor: 11.527

8.  Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities.

Authors:  V Falanga; T A Medsger; M Reichlin; G P Rodnan
Journal:  Ann Intern Med       Date:  1986-06       Impact factor: 25.391

9.  Disabling pansclerotic morphea of childhood with extracutaneous manifestations.

Authors:  Mahendra M Kura; Saurabh R Jindal
Journal:  Indian J Dermatol       Date:  2013-03       Impact factor: 1.494

10.  Disabling pansclerotic morphea of childhood--unusual case and management challenges.

Authors:  Ana-Maria Forsea; Aura-Nicoleta Cretu; Ruxandra Ionescu; Calin Giurcaneanu
Journal:  J Med Life       Date:  2008 Jul-Sep
  10 in total
  1 in total

Review 1.  Challenges in the diagnosis and treatment of disabling pansclerotic morphea of childhood: case-based review.

Authors:  Han Jie Soh; Courtney Samuel; Victoria Heaton; William Douglas Renton; Angela Cox; Jane Munro
Journal:  Rheumatol Int       Date:  2019-03-05       Impact factor: 2.631

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.